肝癌:进展和优先事项
Katherine A McGlynn1, Jessica L Petrick2, John D Groopman3
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
概括
由于病毒性肝炎和代谢状况等风险因素的变化,肝癌发病率在全球范围内发生变化. 预防工作必须解决弱势群体的这些转变和差异.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 公共卫生和流行病学
背景情况:
- 肝癌是全球主要的健康问题,在全球发病率上排名第六,死亡率排名第三.
- 肝癌发病率存在显著的地理差异,最近的趋势显示,一些高风险地区的发病率正在下降,而其他地区的发病率正在增加.
- 风险因素格局的变化,包括病毒性肝炎和新出现的代谢条件,正在推动这些流行病学变化.
研究的目的:
- 分析肝癌发病率和死亡率的流行病学趋势.
- 确定既定和新出现的风险因素对这些趋势的影响.
- 为弱势群体强调预防和公平研究的重要性.
主要方法:
- 全球肝癌发病率和死亡率数据的分析.
- 评估各种风险因素的贡献,包括病毒性肝炎和代谢综合征.
- 检查影响肝癌患病率的社会经济因素.
主要成果:
- 全球肝癌发病率和死亡率呈现出显著的地理差异.
- 趋势表明,一些高发病率地区的发病率下降,而其他地区的发病率增加,这与不断变化的风险因素有关.
- 乙型肝炎和C型肝炎病毒 (HBV/HCV) 控制已取得成功,但代谢条件是肝癌的越来越重要的驱动因素.
- 肝癌不成比例地影响着社会经济贫困人口.
结论:
- 肝癌流行病学是动态的,受到病毒和代谢风险因素的影响.
- 需要继续努力打击病毒性肝炎,并应对日益增长的代谢性疾病负担.
- 公平获得研究,早期诊断和治疗至关重要,特别是对于弱势和处境不利的社区.
更多相关视频
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
338
13:57Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
133
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K